Rapamycin treatment in CRC increased Myc/p-Myc levels, whereas overexpression of circ_0001766 and PPP1R3C with rapamycin treatment successfully inhibited Myc/p-Myc, leading to a significant reduction in CRC proliferation and anti-apoptosis. Here, PPP1R3C is linked to colorectal carcinoma.